Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension

A legfontosabb adatok

Ki végzi
The First Affiliated Hospital with Nanjing Medical University
Hol
Kína3 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Leállítva
Résztvevők
103 fő vett részt
Kezdés
2021. nov. 1.
Befejezés
2023. nov. 20.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • focused power ultrasound mediate inferior perirenal adipose tussue modification
  • sham-control group
A regiszteradat frissítve
2023. december 7.
Miért állt le
Till interim analysis, 100 cases were enrolled, 71 of which during the COVID-19. Affected by epidemic control policy, 58 cases had examination window exceeded or missed, causing significant impact on endpoints, so we decided to terminate the trial.

Ki vehet részt

Életkor
18 év – 65 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 20 feltétel megnézéseKevesebb

Ki vehet részt

  • Individual has office systolic blood pressure (SBP) ≥ 140 mmHg and <180 mmHg when receiving a medication regimen of one, two, or three antihypertensive medication classes;
  • Individual has 24-hour Ambulatory Blood Pressure Monitoring (ABPM) average SBP≥135 mmHg;
  • The anteroposterior, transverse and axial diameters of inferior perirenal fat pad measured by ultrasound should be at least 20mm;
  • Individual is willing to sign the informed consent of the study

Ki nem vehet részt

  • Individual is diagnosed as secondary hypertension (e.g. renal parenchymal hypertension, renal artery stenosis, primary aldosteronism, pheochromocytoma, Cushing's syndrome, aortic coarctation, obstructive sleep apnea hypopnea syndrome);
  • Individual has history of kidney and or kidney surrounding tissue surgery
  • Individual has myocardial infarction, unstable angina pectoris, cerebrovascular accident or transient ischemic attack within 6 months of enrollment
  • Individual has type 1 diabetes or poorly-controlled type 2 diabetes;
  • Individual has severe structural heart disease (e.g. heart valve disease, cardiomyopathy, congenital heart disease)
  • Individual has infected waist skin
  • Individual has malignant tumor
  • Individuals has impairment of liver or kidney function (ALT, AST or creatinine is greater than 2 times of the upper limit of normal reference)
  • Individual has uncontrolled thyroid dysfunction
  • Individual has urinary calculi and/or hematuria;
  • Individual has atrial fibrillation
  • Individual has second degree and above atrioventricular block;
  • Individual has abnormal coagulation function
  • Individual is pregnant, nursing or planning to be pregnant
  • Individual is unwilling to sign informed consent
  • Individual fails to complete the screening period

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This randomized, double blinded, sham-control trial aims to evaluate the efficacy and safety of a novel focused power ultrasound mediated inferior perirenal adipose tissue modification therapy for essential hypertension.

A vizsgálat 2 csoportja

  • intervention groupA vizsgált kezelés

    In intervention group, participants will receive the whole peri-renal fat modification therapy (including peri-renal fat ultrasonic measurement and localization,focused ultrasound treatment parameters setting and initiating)

    Kezelés: focused power ultrasound mediate inferior perirenal adipose tussue modification

  • sham-control groupSzínlelt kezelés, összehasonlításként

    In sham control group, participants will receive the sham control therapy(including peri-renal fat ultrasonic measurement and localization,focused ultrasound treatment parameters setting),however,without initiating the focused ultrasound equipment.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension: a Multicenter, Randomized, Double-blinded Controlled Trial. PARADISE Study
Publikációk
A regiszteradat frissítve
2023. december 7.